Koers Cytek Biosciences, Inc.
Aandelen
CTKB
US23285D1090
Geavanceerde medische apparatuur & technologie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
6,71 USD | +1,21% | +1,51% | -26,43% |
Omzet 2024 * | 208 mln. 193 mln. | Omzet 2025 * | 247 mln. 229 mln. | Marktkapitalisatie | 878 mln. 814 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -8 mln. -7,42 mln. | Nettowinst (verlies) 2025 * | 7 mln. 6,49 mln. | EV/omzet 2024 * | 3,14 x |
Nettoliquiditeiten 2024 * | 225 mln. 209 mln. | Nettoliquiditeiten 2025 * | 240 mln. 222 mln. | EV/omzet 2025 * | 2,58 x |
K/w-verhouding 2024 * |
-106
x | K/w-verhouding 2025 * |
74,6
x | Werknemers | 676 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 94,78% |
Recentste transcriptie over Cytek Biosciences, Inc.
1 dag | +1,21% | ||
1 week | +1,51% | ||
Lopende maand | -12,86% | ||
1 maand | -23,23% | ||
3 maanden | -28,99% | ||
6 maanden | +10,73% | ||
Lopend jaar | -26,43% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ming Yan
FOU | Founder | 61 | 01-12-14 |
Wen Bin Jiang
FOU | Founder | 60 | 01-12-14 |
Chris Williams
COO | Chief Operating Officer | 55 | 31-10-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Donnie Hardison
BRD | Director/Board Member | 74 | 01-06-22 |
Deborah Neff
BRD | Director/Board Member | 71 | - |
Jack Ball
BRD | Director/Board Member | 77 | 13-11-18 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.19% | 26 M€ | +0,78% | - | |
0.11% | 0 M€ | 0,00% | - | |
0.11% | 46 M€ | +4,23% | ||
0.08% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 6,71 | +1,21% | 684 001 |
27-03-24 | 6,63 | +5,41% | 533 857 |
26-03-24 | 6,29 | -1,56% | 966 850 |
25-03-24 | 6,39 | -1,24% | 495 008 |
22-03-24 | 6,47 | -2,12% | 747 175 |
uitgestelde koers Nasdaq, 28 maart 2024 om 21:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-26,43% | 867 mln. | |
+9,50% | 221 mld. | |
+7,95% | 184 mld. | |
+18,30% | 142 mld. | |
+18,47% | 101 mld. | |
+7,83% | 68,07 mld. | |
+25,32% | 57,27 mld. | |
-3,69% | 47,42 mld. | |
+4,66% | 43,19 mld. | |
+15,12% | 28,84 mld. |